Systemic therapy for pretreated advanced biliary tract cancer: past developments and recent advancesNaohiro Okano, Shuichi Hironaka, Fares Jamal et al.|Japanese Journal of Clinical Oncology|2025Cited by 1
328P Time toxicity (TT) associated with first-line treatment (1L) in patients (pts) with advanced biliary tract cancer (aBTC)Naohiro Okano, Mitesh J. Borad, Anna Virginia Adriana Pirozzi et al.|Annals of Oncology|2025Cited by 0
Time Toxicity in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine Plus Cisplatin With or Without DurvalumabN. Okano, Mitesh J. Borad, Angelo Pirozzi et al.|JCO oncology advances.|2026Cited by 0